www.syneoshealth.com
Open in
urlscan Pro
3.209.175.156
Public Scan
Submitted URL: http://syneoshealth.com/
Effective URL: https://www.syneoshealth.com/
Submission: On November 16 via manual from TR — Scanned from DE
Effective URL: https://www.syneoshealth.com/
Submission: On November 16 via manual from TR — Scanned from DE
Form analysis
1 forms found in the DOMPOST /
<form action="/" method="post" id="search-block-form" accept-charset="UTF-8">
<div>
<div class="container-inline">
<h2 class="element-invisible">Search form</h2>
<div class="form-item form-type-textfield form-item-search-block-form">
<label class="element-invisible" for="edit-search-block-form--2">Search </label>
<input title="Enter the terms you wish to search for." type="text" id="edit-search-block-form--2" name="search_block_form" value="" size="15" maxlength="128" class="form-text">
</div>
<div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit" name="op" value="Search" class="form-submit"></div><input type="hidden" name="form_build_id"
value="form-Kb6w6wzq7w3JqNAJboqV-SyDx3zBzG4xLRyD3ie39fI">
<input type="hidden" name="form_id" value="search_block_form">
</div>
</div>
</form>
Text Content
* Our Company * Biopharmaceutical Acceleration Model® * Dynamic Assembly® * Kinetic™ * Syneos One® * The Trusted Process® * Our Leadership * Our Vision, Mission and Values * Resource Library * Events * Awards * Site Relationships * Our Office Locations * Solutions * Clinical Development * Full Service * Decentralized Solutions * Bioanalytical Solutions * Early Phase * Phase II - III * Phase IIIb - IV * Real World and Late Phase * Medical Device and Diagnostics * FSP 360 * Biostatistics and Statistical Programming * Clinical Data Management * Clinical Development Services Project Management * Clinical Monitoring * Drug Safety and Pharmacovigilance * Investigator Management Solutions * Medical Writing and Communications * Rater Training * Site Start Up * Site and Patient Access * Trial Master File Operations * Commercialization * Advertising * AnswerSuite * Behavioral Insights * Brand Commercialization * Brand Naming and Development * Clinical Field Teams * Commercial Model of the Future * Commercial Recruiting Solutions * Communications * Deployment Solutions * Digital and Social Media * Health Economics and Outcomes Research * Integrated Commercial Solutions * Medical Affairs Transformation * Medical Communications * Policy and Advocacy * Portfolio Strategy * Public Relations * REMS and Risk Management (PMO) * Reputation and Risk Management * Selling Solutions * Training and Learning Solutions * Value and Access * Consulting * Commercial Advisory Group * Portfolio Strategy and Transactions * Health Economics and Outcomes Research * Product and Franchise Strategy * Value and Access * Customer and Digital Engagement * Scientific and Medical Affairs Advisory Group * Medical Affairs * Quality and Compliance * Regulatory * Risk and Program Management Advisory Group * REMS and Risk Management (PMO) * R&D Advisory Group * Research and Development * Syneos One® * Therapeutic Expertise * Therapeutic Areas * Cardiovascular * Central Nervous System * CNS Analgesia * CNS Clinical Surveillance Team * CNS Neurology * CNS Psychiatry * Endocrine and Metabolic * Gastroenterology * Immunology and Inflammation * Infectious Disease and Vaccines * Ophthalmology * Respiratory * Women's Health * Oncology and Hematology * Targeted Therapies * Novel and Emerging Therapies * Immuno-Oncology * Cross-Functional Solutions * Biosimilars * Cell and Gene Therapy * Patient Voice * Pediatrics * Rare Diseases * Our Experience Hub * Insights Hub * Careers * インサイト ハブ * 中途採用 * 新卒採用 (日本) * News * In The News * Press Releases * Press Kit * Investors * Investigators * Transparency * Suppliers * Supplier Code of Conduct * Standard Contractual Clauses for Suppliers * Supplier Diversity and Inclusion * Supplier Terms and Conditions * Contact * Investors * Investigators * Transparency * Suppliers * Supplier Code of Conduct * Standard Contractual Clauses for Suppliers * Supplier Diversity and Inclusion * Supplier Terms and Conditions * Contact * English * English * Français Canadien * 日本語 English * English * Français Canadien * 日本語 SEARCH FORM Search MENU * Our Company * Biopharmaceutical Acceleration Model® * Dynamic Assembly® * Kinetic™ * Syneos One® * The Trusted Process® * Our Leadership * Our Vision, Mission and Values * Resource Library * Events * Awards * Site Relationships * Our Office Locations * Solutions * Clinical Development * Full Service * Decentralized Solutions * Bioanalytical Solutions * Early Phase * Phase II - III * Phase IIIb - IV * Real World and Late Phase * Medical Device and Diagnostics * FSP 360 * Biostatistics and Statistical Programming * Clinical Data Management * Clinical Development Services Project Management * Clinical Monitoring * Drug Safety and Pharmacovigilance * Investigator Management Solutions * Medical Writing and Communications * Rater Training * Site Start Up * Site and Patient Access * Trial Master File Operations * Commercialization * Advertising * AnswerSuite * Behavioral Insights * Brand Commercialization * Brand Naming and Development * Clinical Field Teams * Commercial Model of the Future * Commercial Recruiting Solutions * Communications * Deployment Solutions * Digital and Social Media * Health Economics and Outcomes Research * Integrated Commercial Solutions * Medical Affairs Transformation * Medical Communications * Policy and Advocacy * Portfolio Strategy * Public Relations * REMS and Risk Management (PMO) * Reputation and Risk Management * Selling Solutions * Training and Learning Solutions * Value and Access * Consulting * Commercial Advisory Group * Portfolio Strategy and Transactions * Health Economics and Outcomes Research * Product and Franchise Strategy * Value and Access * Customer and Digital Engagement * Scientific and Medical Affairs Advisory Group * Medical Affairs * Quality and Compliance * Regulatory * Risk and Program Management Advisory Group * REMS and Risk Management (PMO) * R&D Advisory Group * Research and Development * Syneos One® * Therapeutic Expertise * Therapeutic Areas * Cardiovascular * Central Nervous System * CNS Analgesia * CNS Clinical Surveillance Team * CNS Neurology * CNS Psychiatry * Endocrine and Metabolic * Gastroenterology * Immunology and Inflammation * Infectious Disease and Vaccines * Ophthalmology * Respiratory * Women's Health * Oncology and Hematology * Targeted Therapies * Novel and Emerging Therapies * Immuno-Oncology * Cross-Functional Solutions * Biosimilars * Cell and Gene Therapy * Patient Voice * Pediatrics * Rare Diseases * Our Experience Hub * Insights Hub * Careers * インサイト ハブ * 中途採用 * 新卒採用 (日本) * News * In The News * Press Releases * Press Kit * Investors * Investigators * Transparency * Suppliers * Supplier Code of Conduct * Standard Contractual Clauses for Suppliers * Supplier Diversity and Inclusion * Supplier Terms and Conditions * Contact Upcoming Webinar: Investing for Launch Success LEARN WHEN, WHERE AND HOW MUCH TO INVEST TO MAXIMIZE YOUR ASSET’S LAUNCH POTENTIAL. Register Now Webinar Series A DISCUSSION OF THE CURRENT CHALLENGES AND OPPORTUNITIES IN BIOSIMILAR DEVELOPMENT AND COMMERCIALIZATION. Register Now WEBINAR: UNLOCKING UNPRECEDENTED VALUE: THE ADVENT OF THE ESTABLISHED BRAND Register Now 1. 2. 3. パーソルファーマパートナーズ株式会社の買収のお知らせ 医薬品開発業務受託機関(CRO)およびコマーシャルビジネス受託機関(CCO)として、業界で唯一、バイオ医薬品に関するソリューションを統合的に提供するサイネオス・ヘルスは、令和3年4月30日付で、パーソルホールディングス株式会社から、その完全子会社であるパーソルファーマパートナーズ株式会社を買収したことをお知らせ申し上げます。今後も倍旧のご愛顧、お引き立てを賜りますよう謹んでお願い申し上げます。 ACQUISITION OF PERSOL PHARMA PARTNERS CO., LTD. BY SYNEOS HEALTH Effective April 30, 2021, Syneos Health, the only fully integrated biopharmaceutical solutions organization including a Contract Research Organization and Contract Commercial Organization, has acquired Persol Pharma Partners Co., Ltd., a wholly owned subsidiary of Persol Holdings Co., Ltd.. We would like to take this opportunity to thank you for your business and would greatly appreciate your continued support in the future. 1. LA BIBLIOTHÈQUE VIRTUELLE INSIGHTS HUB DE SYNEOS HEALTH PUBLIE L’ARTICLE 2020 HEALTH TRENDS -------------------------------------------------------------------------------- SUR LES 15 TENDANCES QUI INFLUERONT SUR L’INDUSTRIE DES SOINS DE SANTÉ AU COURS DE LA PROCHAINE ANNÉE LE CONTENU CI-DESSOUS EST DISPONIBLE UNIQUEMENT EN ANGLAIS. Scroll NOT JUST SERVICES - SOLUTIONS Learn About Our Solutions * CLINICAL DEVELOPMENT Our fit-for-purpose CRO solutions are tailored to your product and requirements. * COMMERCIALIZATION We improve brand performance by leveraging data and insights and deep therapeutic expertise. * CONSULTING Our consulting practitioners span the entire product development and delivery continuum. Learn About Our Solutions OUR THERAPEUTIC EXPERTISE Learn About Our Therapeutic Expertise * THERAPEUTIC AREAS Discover More * CROSS-FUNCTIONAL SOLUTIONS Discover More Learn About Our Therapeutic Expertise ACCELERATING YOUR SUCCESS * DECENTRALIZED SOLUTIONS Consultative problem-solving to address the unique nuances of your trial. Discover More * SYNEOS ONE® Our end-to-end offering giving you true control and ownership of your asset while helping you maximize ROI. Discover More * REAL WORLD EVIDENCE Our unique RWE approach drives better solutions, from regulatory to operations and patient adherence. Discover More サイネオス・ヘルス グループについて 2018年7月1日より、INC Research Japan株式会社とインヴェンティヴ・ヘルス・ジャパン合同会社は、サイネオス・ヘルス・グループとして新たにスタートいたしました。この事業再編により、ホールディングカンパニー傘下に2社の事業体を有する形となります。それに伴い、旧社名変更等を実施いたしました。各社詳細は、以下の通りです。 Syneos Health G.K. サイネオス・ヘルス合同会社 代表取締役 スティファン グトウ 職務執行者 タン・キット・イン サイネオス・ヘルス合同会社は、サイネオス・ヘルス・コマーシャル株式会社とサイネオス・ヘルス・クリニカル株式会社の持ち株会社です。2社の株式保有ならびに日本およびアジア太平洋地域のサイネオス・ヘルス グループ各社の事業支援を行います。 Syneos Health Commercial K.K. サイネオス・ヘルス・コマーシャル株式会社 代表取締役 セオドア・シーチャオ・ウォン サイネオス・ヘルス・コマーシャル株式会社は今回の事業再編のため新たに設立され、旧インヴェンティヴ・ヘルス・ジャパン合同会社よりコマーシャル事業を継承しました。この新会社が日本においてコマーシャル事業を展開いたします。 Syneos Health Clinical K.K. サイネオス・ヘルス・クリニカル株式会社 代表取締役 スティファン グトウ 旧INC Research Japan株式会社は、旧インヴェンティヴ・ヘルス・ジャパン合同会社より、クリニカル事業を承継、統合のうえ、サイネオス・ヘルス・クリニカル株式会社と社名を変更いたしました。日本においてクリニカル事業を展開いたします。 より迅速なプロセス、より深い洞察、より効率的なシステム、より実用的なリアルワールド・エビデンス、およびそれらに対する理解。これらは、サイネオス・ヘルスと「バイオ医薬品ビジネスの加速化」が、日々複雑化を増し、競争が激化する医薬品市場にもたらすメリットの一部です。 ISO9001認証を取得しました。詳細についてこちらをご覧ください。 JOIN OUR TEAM Learn About Syneos Health Careers STEFAN Manager Stat Programming You wake up in the morning and you know that your work helps people to get healthy or stay healthy - that’s a nice thing to know. * PHARMACEUTICAL CONSULTANT Discover More * PHARMACEUTICAL SALES REPRESENTATIVE Discover More * CLINICAL RESEARCH ASSOCIATE Discover More * PROJECT MANAGERS Discover More Learn About Syneos Health Careers WHAT'S HAPPENING Discover Syneos Health Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization Read the News Syneos Health Supports ACRO Statement on COVID-19 Vaccines Read the News Syneos Health Colleagues Choose to Challenge Gender Disparity on International Women’s Day and Beyond Watch the Video Acting on Equity: A Discussion on Inequalities in Healthcare & What Pharma is Doing to Champion Under-represented Populations Watch the Video Syneos Health Colleagues Choose to Challenge Gender Disparity on International Women’s Day and Beyond Watch the Video Acting on Equity: A Discussion on Inequalities in Healthcare & What Pharma is Doing to Champion Under-represented Populations Watch the Video Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization Read the News Syneos Health Supports ACRO Statement on COVID-19 Vaccines Read the News Syneos Health Colleagues Choose to Challenge Gender Disparity on International Women’s Day and Beyond Watch the Video Acting on Equity: A Discussion on Inequalities in Healthcare & What Pharma is Doing to Champion Under-represented Populations Watch the Video Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization Read the News Syneos Health Supports ACRO Statement on COVID-19 Vaccines Read the News * 1 * 2 * 3 * 4 INTERESTED IN SYNEOS HEALTH? Get In Touch CONNECT * * * * Syneos Health Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 28,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Contact Us Corporate Headquarters * 1030 Sync Street * * Morrisville, NC 27560 * * Phone: +1 919 876 9300 * Fax: +1 919 876 9360 * Toll-Free: +1 866 462 7373 Menu * Solutions * Therapeutic Expertise * Brand Directory * 労働者派遣法に基づく情報公開 * Careers * Study Participants * Media * Business Ethics Helpline * Events * Transparency © 2021 Syneos Health. All Rights Reserved. * Terms Of Use * Privacy Notice * Privacy Shield * Online Tracking Opt-Out About Cookies On This Site We store your consent for 6 months with 19 partners for Ad Exchange, Ad Network, Ad Server, Analytics Provider, Business Intelligence, Data Aggregator/Supplier, Mobile, Other, Publisher, Social Media, Tag Manager. Read our policy Accept AllManage Settings Show PurposesShow Vendors